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Abstract 
 
Background: Relatively few studies have focused on the validation of psychometric scales 
measuring depression during pregnancy. The aim of this review was to critically appraise and 
review antenatal validation studies of the Edinburgh Postnatal Depression Scale (EPDS).  
Methods: A systematic search was performed in MEDLINE, EMBASE, ISI, CINAHL, 
SCIELO and PsyCINFO for the period 1987–2013. 
Results: Eleven validation studies met the inclusion criteria. The study design varied between 
studies. Sensitivity and specificity estimates also varied between 64–100% and 73–100%, 
respectively. The confidence interval estimates also showed a high degree of variability. Our 
estimates suggest lower positive predictive values in the general population than those 
reported in the validation study samples. The sensitivity values in validation studies of the 
EPDS show fairly large variability, ranging from good to acceptable. 
Limitations 
Future studies should have larger sample sizes and include both representative and clinical 
samples and look at the psychometric performance of the EPDS in each trimester. 
Conclusions: Due to differences in study design and variation in the cultural/linguistic 
adaptation, uncertainty remains regarding the comparability of the sensitivity and specificity 
estimates of different EPDS versions. Future studies should have larger sample sizes, include 
both representative and clinical samples, and look at the psychometric performance of the 
EPDS in each trimester. Reporting quality, especially as regards checks to ensure content 
validity, should be improved. 
Highlights 
 There is a wide variation across different settings in screening properties in validation 
studies. 
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 Cultural variations are likely to account for the majority of this variation.  
 Each local version of the EPDS should be validated in its own culture. 
Keywords: Edinburgh Postnatal Depression Scale, antepartum, validation, review 
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Introduction 
 
Antenatal major depressive disorder is a major health problem with a prevalence 
ranging from 3.1–4.9%. Taken together with the minor forms of the illness the point 
prevalence rises to 8.5–11.0% during pregnancy (Gaynes et al., 2005, Kuijpens et al., 2001). 
It is therefore essential that we have a tool to detect this illness effectively in those at risk. The 
Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-rating scale, was developed by 
Cox et al. in 1987, originally to detect postnatal depression (Cox et al., 1987). The EPDS was 
constructed from the Snaith’s Irritability, Depression and Anxiety Scale (Snaith et al., 1978) 
and the Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983) in addition to 
items formulated by the constructors (Cox et al., 1987).  
Antenatal depression (AND) often remains unnoticed by health professionals, 
although it could be detected using self-report scales which are economical and do not require 
extensive rater training. The EPDS is the most widely used screening instrument perinatally, 
and it has also been validated in a non-gestational context showing good psychometric 
properties amongst men (Matthey et al., 2001), infertile women (Peterson et al., 2006), in the 
perimenopausal period (Becht et al., 2001), and in women who were not pregnant, apart from 
its original context, post partum (Cox et al., 1996). Without trying to be exhaustive, the 
question as to whether the EPDS is a uni- or multidimensional scale has also been studied in 
both perinatal and non-gestational contexts with Pop et al (1992), Töreki et al (2014) and 
Adouard et al (2005) identifying 2 dimensions, whereas Bergink et al (2011) and de Cock et 
al (2011) reaching a conclusion of unidimensionality. Before use, a scale devised in another 
culture, needs to go through cultural validation in order to ensure it is suitable for use in the 
target population. However, as pointed out by Matthey et al. (Matthey et al., 2006), the EPDS 
has often been used, without proper validation, during pregnancy for screening out probable 
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depressive cases with a cut-off defined through a postnatal validation procedure (Kim et al., 
2008; Lommatsch et al., 2006; Doornbos et al., 2009; Schultze-Herbrüggen et al., 2007; de 
Tychey et al., 2005; Otake et al., 2013; Koutra et al., 2013). Furthermore, it seems that 
different validation sessions are needed for each trimester of the pregnancy (Bergink et al., 
2011; Su et al., 2007; Bunevicius et al., 2009a), suggested by different cut-offs found in three 
validation studies during the course of pregnancy (Bergink et al., 2011; Su et al., 2007; 
Bunevicius et al., 2009a). Consequently, it could be methodologically incorrect to recruit 
women for the validation of the EPDS both before and after giving birth (Tran et al., 2011; 
Hanlon et al., 2008; Werrett and Clifford, 2006; Areias et al., 1996), that is, to validate the 
scale in a perinatal sample. The EPDS, with its items retained, has been renamed as the 
Edinburgh Depression Scale (EDS), to take into consideration its new use in the antenatal 
period. 
Recent studies have repeatedly shown that mental health problems during pregnancy 
(e.g., depression or anxiety) are associated with impaired obstetric and neonatal outcomes, 
although some studies found no correlation (Choi et al., 2014; Räisänen et al., 2014). 
Antenatal stress and depression, for example, have been linked to preterm birth and impaired 
physical health (Dayan et al., 2006; Suri et al., 2007; Rahman et al., 2004), as well as to future 
emotional, behavioural, and cognitive problems in the child (Talge et al., 2007; Deave et al., 
2008; O’Connor et al., 2002). Although we have little direct evidence available so far to prove 
that the treatment of perinatal depression improves obstetric outcome (Engelstad et al., 2014; 
Lindqvist et al., 2014) or good quality evidence that depression screening improves 
depression outcome (Thombs et al., 2014), there is enough evidence to suggest that maternal 
depression is linked to poor maternal and infant health outcomes that argues in favour of 
improving routine screening during pregnancy. 
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Early screening for antenatal depression is recommended by some national 
professional bodies, such as the UK’s National Institute for Health and Clinical Excellence 
(NICE 2007) (“Antenatal and postnatal mental health: clinical management and service 
guidance”). Therefore, there is a well-defined and expressed need for an easy-to-administer 
self-report scale that can be used by healthcare professionals, such as midwives, obstetricians, 
health visitors, and family doctors. 
There is a disagreement around whether pregnancy is a risk or a protective factor for 
mood disorders (Bergink et al., 2011; Cox, Chapman et al., 1996; Töreki et al., 2013; Töreki 
et al., 2014). Having a cross-culturally valid screening instrument would be very helpful in 
settling this question. 
Investigators using the EPDS to screen for depression should realize that the 
instrument does not exclusively measure depression but anxiety too (Brouwers et al., 2001, 
Matthey et al., 2013). This, however, is more of an added benefit rather than a problem, as 
anxiety disorders, when discovered, can also be effectively treated. 
A large review study (Gibson et al., 2009) has previously been published on the 
validity of the EPDS in both ante- and postnatal depression, however that review could only 
include three antenatal studies. Since the publication of the Gibson review (Gibson et al., 
2009), four more antenatal studies (Töreki et al., 2014; Bergink et al., 2011; Rubertsson et al., 
2011; Stewart et al., 2013; Wang et al., 2009) have been published and the conclusions from 
these highlight the need for making appropriate recommendations in the light of the newly 
published material. 
 
Aims of the Study 
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The primary objective of this study was to identify all published antenatal validation 
studies on the EPDS and to present their design along with the estimated sensitivity, 
specificity and positive and negative predictive values. An additional aim was to estimate the 
95% confidence intervals of the screening values on the basis of the sample sizes and detected 
depression cases in each study. In addition, we assessed the association between the 
prevalence of antenatal depression and the estimates of the positive and negative predictive 
values of the Edinburgh Postnatal Depression Scale and the interrelation between the true and 
false positive rates of validation studies. 
 
Methods 
 
Search strategy 
 
Previous validation studies of the EPDS during pregnancy in the English–language 
literature were identified through the MEDLINE, EMBASE, ISI, CINAHL, SCIELO, 
Cochrane Library and PsyCINFO databases from 1987 onwards, when the EPDS was 
launched, until December 2013, using the following search terms: ’Edinburgh postnatal 
depression scale’ OR ‘EPDS’ OR ‘scale’ OR ‘tool’ OR ‘inventory’ OR ‘questionnaire’ AND 
‘valid?’ OR ‘screen’ OR ‘Diagnos?’ OR ‘semi?structured’ OR ‘interview’ OR ‘Valid’ OR 
‘Sensitivity’ OR ‘Specificity’ OR ‘predict?’ OR ‘value’ OR ‘PPV’ OR ‘NPV’ OR ‘likelihood 
ratio’ OR ‘ROC’ OR ‘AUC’ AND ‘antepartum’ OR ‘antenatal’ OR ‘pregnancy’ OR 
‘prenatal’ OR ‘diagnosis’ in the title, keywords, or anywhere in the abstract. All abstracts 
were read by two reviewers (Z.K. and R.D.) to identify relevant papers. Extensive additional 
searching was carried out manually, using the reference lists of published papers. 
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Data quality 
 
The quality of the selected studies was assessed using a grading system based on the 
York CRD system (Khan et al., 2001). Each study was assigned a grade on the basis of 
whether the clinicians were appropriately blinded to the EPDS scores, what reference 
standards were used for diagnosis and the sampling method used. 
 
Data analysis 
 
We tabulated the extracted data and analyzed the screening properties of EPDS for 
antenatal depression. With the exception of one study (Bergink et al., 2011), relatively small 
numbers of women were included in the validation studies identified. Also, the studies aimed 
at choosing a cut-off score that allowed the highest sensitivity value without compromising 
too much on specificity (Krzanowski and Hand, 2009). The Wilson score method was used 
for presenting confidence intervals, because diagnosis is a binary variable and leads to a 
binomial distribution of the EPDS scores (Wallis, 2013). 
The positive and negative predictive values (PPV and NPV) of the EPDS and their 
confidence intervals were also calculated. Unfortunately, there is no available systematic 
review providing a robust estimate for the point prevalence of major depressive disorder in 
each trimester in the literature. Prevalence estimates from a meta-analysis would be more 
representative of the countries in which the included studies were carried out. Consequently, 
estimation of PPV/NPV is not possible for major depressive episode. For combined 
depression (major depressive episode and minor depression), re-estimated PPVs and NPVs, 
assuming 7.4%, 12.8% and 12.0% prevalences of combined depression in the first, second 
and third trimester, respectively, based on the review of Bennett et al. (Bennett et al., 2004), 
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were calculated. According to Eberhard-Gran et al. (Eberhard-Gran et al., 2001), predictive 
values were also estimated at assumed prevalence rates of antenatal depression at 5, 10, 15, 20 
and 25%, respectively. Similar to Gibson et al (Gibson et al., 2009), the results were plotted 
from studies reporting findings for major and combined depression on a scatterplot of true-
positive rate (sensitivity) against false-positive rate (1 - specificity), and calculated relevant 
summary statistics. 
All statistics were calculated using Statistical Package for Social Sciences (SPSS), 
Version 20 (SPSS Inc., Chicago, IL, USA). 
 
Results 
 
Search results 
 
The search strategy identified 11 EPDS validation studies in the antenatal period 
(Bunevicius et al., 2009a; Su et al., 2007; Felice et al., 2006; Adewuya et al., 2006; Bergink et 
al., 2011; Adouard et al., 2005; Murray and Cox, 1990; Wang et al., 2009; Rubertsson et al., 
2011; Stewart et al., 2013; Töreki et al., 2014), reporting that the EPDS was a valid screening 
instrument for depressive disorders during pregnancy in 11 different countries. The reference 
lists in these publications did not include any other validation studies.  
Table 1 presents the identified antenatal validation studies. The optimal cut-off for 
major depression varied from 5.5 to 14.5 (Stewart et al., 2013; Bunevicius et al., 2009a; Su et 
al., 2007; Felice et al., 2006; Adewuya et al., 2006; Adouard et al., 2005; Murray and Cox, 
1990; Wang et al., 2009; Töreki et al., 2014), whereas for combined depression from 4.5 to 
13.5 (Stewart et al., 2013; Rubertsson et al., 2011; Felice et al., 2006; Adewuya et al., 2006; 
Adouard et al., 2005; Murray and Cox, 1990; Töreki et al., 2014). It is of note that only two 
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studies have evaluated the performance of the EPDS in each trimester (Bergink et al., 2011; 
Bunevicius et al., 2009a) and they identified different cut-offs. The Taiwanese version of 
EPDS was validated in the second and third trimester and, again, found different optimal cut-
offs (Su et al., 2007). The Maltese version (Felice et al., 2006) was validated among women 
taken at any time point during the pregnancy, while other researchers validated the EPDS at 
the end of the first trimester (Töreki et al., 2014), in the first half of the pregnancy 
(Rubertsson et al., 2011) or in late pregnancy (third trimester) (Adewuya et al., 2006; 
Adouard et al., 2005; Murray and Cox, 1990; Wang et al., 2009; Stewart et al., 2013). 
 
Study sample/selection 
 
The size of the study sample varied between 60 and 845 women interviewed. In the 
validation study by Murray and Cox (Murray and Cox, 1990), available mothers were 
recruited ad hoc by a health care provider and they completed the EPDS before the interview. 
In some studies (Töreki et al., 2014; Bunevicius et al., 2009a), unselected clinical subjects 
were recruited in random order or by random number generation during a daily recruitment 
process (Felice et al., 2006). However, in the French study targeted to validate the EPDS in 
high-risk pregnancies, women were recruited ad hoc by a health-care provider directing them 
to a psychiatrist who carried out the questionnaire survey and the interview (Adouard et al., 
2005). The selection process was not adequately described in the Taiwanese study, where a 
research assistant recruited the participants completing the questionnaire before the interview 
carried out by the psychiatrist (Su et al., 2007). In other studies (Adewuya AO et al., 2013; 
Rubertsson et al., 2011), the participants were recruited consecutively, whilst all women with 
high scores and a random sample of women with low scores from a population-based study 
were included. Pregnant women were recruited as a medium or large, community-based 
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sample in only two studies (Wang et al., 2009; Bergink et al., 2011) (Table 1). 6 studies did 
not report the percentage of women who declined participation, and the remaining 5 reported 
0-25 percent. 
 
Diagnostic criteria 
 
In an earlier validation study (Murray & Cox, 1990), the EPDS was validated against 
the Research Diagnostic Criteria (RDC) set for depression, distinguishing between major, 
minor and intermittent depressive disorder (Spitzer et al., 1975; Spitzer et al., 1978). In most 
of the later studies (Bunevicius et al., 2009a; Töreki et al., 2014; Su et al., 2007; Adewuya et 
al., 2006; Adouard et al., 2005; Wang et al., 2009; Rubertsson et al., 2011; Stewart et al., 
2013), the Diagnostic and Statistical Manual of Mental Disorders (DSM)-III (American 
Psychiatric Association, 1980) or DSM-IV (American Psychiatric Association, 1994) was 
used as gold standard. International Classification of Disease (ICD-10) diagnosis for severe, 
moderate and mild depressive episode (World Health Organization, 1992) has also been used 
as a validation instrument (Felice et al., 2006). Some studies included both major and minor 
depressive disorders in the definition of antenatal depression (Rubertsson et al., 2011; Stewart 
et al., 2013; Murray and Cox, 1990; Töreki et al., 2014; Adewuya et al., 2006) or minor, 
intermittent and major depression (Felice et al., 2006), were used. In four studies, a more 
strict definition, only including major depression, was applied (Wang et al., 2009; Bunevicius 
et al., 2009a; Adouard et al., 2005; Su et al., 2007). The EPDS was validated according to 
DSM-IV (American Psychiatric Association, 1994) and ICD-10 criteria (World Health 
Organization, 1992) in the Netherlands (Bergink et al., 2011) (Table 1). The overall point 
prevalence of major and combined depression extracted from the validation studies was 
5.23% and 11.37%, respectively (not presented in the Tables). 
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Diagnostic instruments 
 
In all studies, the validation was performed with a clinical interview. In order to 
establish the diagnosis of major/minor depression, three studies (Adouard et al., 2005; 
Adewuya et al., 2006; Su et al., 2007) used the Mini International Neuropsychiatric Interview 
(Sheehan et al., 1998), one study (Murray and Cox, 1990) Goldberg’s Standardized 
Psychiatric Interview (Goldberg, 1972), one study (Felice et al., 2006) the Clinical Interview 
Schedule (Lewis et al., 1992), one study (Rubertsson et al., 2011) the Primary Care 
Evaluation of Mental Disorders (PRIME-MD) (Spitzer et al., 1999) and four studies (Stewart 
et al., 2013; Wang et al., 2009; Töreki et al., 2014; Bunevicius et al., 2009a) the Structured 
Clinical Interview for DSM-III/IV (SCID; Spitzer et al., 1990; American Psychiatric 
Association, 1980; American Psychiatric Association, 1994; First et al., 2002). It is of note 
that there was only one study (Töreki et al., 2014) that clearly stated the diagnostic criteria 
used for the diagnosis of both major and minor depression. The EPDS was validated against 
the short version of the Composite International Diagnostic Interview (Robins et al., 1988), a 
structured diagnostic interview, in the Dutch study (Bergink et al., 2011). In all studies 
specially trained investigators (psychiatrists or psychologists) conducted the diagnostic 
interviews, except in the Bergink et al (Bergink et al., 2011) study, in which two third of the 
participants were interviewed by midwives and the remaining by psychology students who 
had been specially trained in the diagnosis of antenatal depression. 
Only two studies evaluated the reliability of the EPDS with repeated measurements in 
all three trimesters of pregnancy (Bergink et al., 2011; Bunevicius et al., 2009a) and another 
one that validated the EPDS in two trimesters (Su et al., 2007), indicating that the EPDS is a 
reliable instrument for repeated evaluations of depressive symptoms. The high test–retest 
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reliability of the EPDS was demonstrated throughout one trimester in two studies (Töreki et 
al., 2014; Wang et al., 2009). 
 
Quality assessment 
 
Table 2 summarizes the results of our quality assessment. Study quality was generally 
acceptable, with four of the eleven studies achieving grade A (Adewuya et al., 2006; Bergink 
et al., 2011; Rubertsson et al., 2011; Stewart et al., 2013) indicating an appropriate study 
design, used in a representative population, and appropriate blinding. The remaining seven 
studies achieved grade B (Adouard et al., 2005; Bunevicius et al., 2009a; Murray and Cox, 
1990; Su et al., 2007; Töreki et al., 2014; Wang et al., 2009) because of having been 
conducted in a narrow population sample. One study (Felice et al., 2006) was hard to classify. 
 
Sensitivity and specificity 
 
The estimates of sensitivity of the EPDS between studies varied from 70% to 100% 
for major depression and from 64 to 87% for combined depression. There was also a large 
variation in specificity from 74% to 97% and from 73% to 96% for major and combined 
depression, respectively (Table 1). Studies with higher cut-off score for major depression did 
not always produce lower sensitivity and higher specificity than studies with a lower cut-off, 
likely reflecting cultural differences. Studies in which a high EPDS cut-off score for 
combined depression was used (Murray and Cox, 1990; Felice et al., 2006; Rubertsson et al., 
2011) generally showed lower sensitivity and higher specificity than the study using a low 
cut-off score (Töreki et al., 2014) did. Stewart used weighted scores and very low cut-off 
values and reported acceptable sensitivity and specificity for both major and combined 
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depression (Stewart et al., 2013). The choice of an appropriate cut-off level was discussed in 
all studies. Receiver operating characteristic (ROC) curve analyses were carried out to assess 
the global performance of the EPDS for detecting depression as a diagnosis, as well as to 
optimize the cut-off points for the EPDS by means of the trapezoidal rule. Inclusion of minor 
depressive disorders in the definition of postnatal depression tends to lower both sensitivity 
and specificity (Table 1). 
 
Confidence intervals 
 
Confidence intervals of the sensitivity and specificity estimates of the EPDS were not 
presented in any of the validation studies and could not be calculated in one study (Wang et 
al., 2009). Our estimates of the 95% confidence intervals for the sensitivity and specificity in 
each study are presented in Table 1. Sensitivity and specificity values were higher and the 
confidence intervals narrower for major depression compared to combined depression. 
Confidence intervals were narrower for specificity than for sensitivity values. Studies that had 
narrower confidence intervals for sensitivity (Adewuya et al., 2006; Bergink et al., 2011; 
Felice et al., 2006; Stewart et al., 2013) generally had higher quality grading, reflecting a 
more representative sample. 
 
Positive and negative predictive values 
 
The positive and negative predictive values (PPVs and NPVs) with confidence 
intervals of the EPDS total scores for the detection of depression for each validation study are 
presented in Table 3, except for the Chinese validation (Wang et al., 2009) where they could 
not be calculated. PPVs ranged between 22% and 75%, whereas NPVs from 92% to 100%. 
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Higher predictive values can be observed at a higher prevalence of antenatal depression. We 
also calculated estimates of these values based on the sensitivity and specificity values 
published in a studies on combined depression, assuming prevalences of 7.4%, 12.8% and 
12.0% of combined depression in the first, second and third trimester, respectively, based on 
the meta-analysis by Bennett et al (Bennett et al., 2004). Our estimates, not very different 
from the values in the original studies, varied from 28% to 69% for PPVs and from 95% to 
98% for NPVs. The differences reflected the possible over-representativity (Felice et al., 
2006; Murray and Cox, 1990; Töreki et al., 2014) or under-representativity (Adewuya et al., 
2006; Rubertsson et al., 2011) of depressed women in the included studies. From all 
validation studies, an overall specificity and sensitivity could be extracted for major 
depression and combined depression in each trimester, and the effect of the changing 
prevalence of major/combined depression in relation to predictive values could be studied 
(Eberhard-Gran et al., 2001). Figure 1 illustrates the impact of the prevalence of antenatal 
depression on the positive predictive value of the EPDS. Figure 2 shows the impact of 
prevalence on negative predictive value. Figure 3 depicts the true-positive rates (sensitivity) 
against false-positive rates (1 - specificity) for major and combined depression of the studies 
reflecting that sensitivity is satisfactorily high with regards to specificity. 
 
Discussion 
 
It is not advisable to use universal cut-off scores, as there can be cultural differences 
and/or differences in how successful the adaptation of the EPDS was in a given culture, 
resulting in differences in at what total score the best trade-off between sensitivity and 
specificity can be found. 
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There is a painful lack of a systematic review on the prevalence of major depressive 
disorder in each trimester. Trimester-specific EPDS validation studies are urgently needed in 
each culture instead of using non-validated cut-offs (Matthey et al., 2001; Matthey et al., 
2006). The UK NICE guidelines recommend screening, but there are no trimester-specific 
cut-offs extracted from ROC-analyses carried out in ante partum validation studies (NICE, 
2007). Generally, the EPDS versions validated in various countries are good at identifying 
major depression alone, with the lowest misclassification rates in studies using community 
samples (Wang et al., 2009; Bergink et al., 2011), but they perform poorer for the combined 
or minor depression categories. As in the previous reviews (Gibson et al., 2009; Eberhard-
Gran et al., 2001), we found that there were significant differences in study design, population 
sampled, the timing of testing, language version of the EPDS used, and how cases were 
diagnosed. Overall, the studies included in this current review have provided evidence for the 
EPDS as a valid screening tool across different cultures, as visible from the satisfactory ROC 
analyses results (Area under curves (AUCs) were greater than 0.7) (Hanley and McNeil, 
1982). However, there was a wide range of sensitivity, specificity and predictive values at all 
cut-off points. One possible explanation for this could be differences in content validity; 
unfortunately, few studies provide sufficiently detailed description to assess this. The high 
sensitivity of the EPDS is clinically desirable for a screening instrument, as it prevents 
missing a depressive disorder (Flaherty et al., 1998). High specificity combined with a high 
negative predictive value also fulfils the requirements for a good screening instrument. It is 
advisable to choose a cut-off at which the misclassification rate is not too high. Lowering the 
cut-off (increasing sensitivity) may make sense for established referral pathways (e.g. primary 
care) where the objective is to maximize detection and referring potential cases  on to 
psychiatry. 
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As with any screening tool, in selecting a cut-off point, there is a trade-off between the 
accuracy of ruling in or out a diagnosis. At lower cut-offs, the EPDS performs considerably 
better overall and generally the studies suggest that it provides ’convincing evidence’ 
(combined depression) or ’strong evidence’ (major depression) by which to rule out the 
diagnosis. 
Whilst sensitivity and specificity do not depend on prevalence, PPV and NPV do, and 
they showed significant variability. There are a number of explanations to be considered. Both 
methodologies and populations varied greatly between the studies. Samples were drawn from 
countries with different cultural attitudes to distress and genuine differences in prevalences. 
Also, different diagnostic interviews and criteria were used. 
Although not possible to analyze due to the low number of studies, in a review of the 
postnatal validation studies (Gibson et al., 2009), it was stated that the language of 
administration of the EPDS contributed to some differences in the heterogeneity of the 
screening properties (Gibson et al., 2009). . 
As the prevalence of the disorder increases, so too does the PPV. Therefore, studies in 
which women with AND were over-represented, showed higher PPV values. Bennett et al., in 
their review, have suggested that the prevalence of depression during pregnancy in the first, 
second and third trimesters are 7.4%, 12.8% and 12.0%, respectively, in the general 
population (Bennett et al., 2004). If the true prevalence is close to this value, the PPVs 
presented in some of the validation studies are misleadingly high (Töreki et al., 2014; Murray 
and Cox, 1990; Felice et al., 2006) or low (Adewuya et al., 2006). This bias is caused by over- 
or under-representation of depressed women in the samples. This can be partly explained by 
the fact that the prevalence of depression is higher in clinical (as opposed to community) 
settings (Eberhard-Gran et al., 2001). 
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Whilst the included studies scored well on the quality rating scale  there were some 
general weaknesses. The method of selection of study samples was not always clearly 
described and in some cases was ’ad hoc’, which may bias the results towards including more 
motivated or psychologically vulnerable women, or under-representing women who were 
depressed during pregnancy. This method of sampling may under-represent women with 
depression, chiefly in those cultures, where the prevalence of depression is low. One of the 
studies (Adouard et al., 2005) was conducted on a narrowly defined population, e.g. women 
who had experienced obstetric complications, and the results are not likely to be generalizable 
to a standard community setting. 
The relatively wide range of values for sensitivity, specificity and predictive values 
and their confidence intervals across studies make the interpretation of the utility of this 
screening instrument more complicated. The heterogeneity in the figures may suggest that the 
accuracy of the EPDS varies depending on the clinical setting, country, and language of 
administration. 
At present, when the EPDS is used in the general population, it will yield a substantial 
proportion of false positives, which is costly to service providers, because it generates 
unnecessary further assessment. Also, the EPDS will miss a considerable number of cases, 
similar to the majority of other screening tools. The advantage of the EPDS rests in its free 
availability, ease of administration and general acceptability to women, if given 
sympathetically. Therefore, if the above caveats are observed, it remains a useful tool in the 
field of perinatal mental health. 
In the validation studies discussed, the identified cut-off for combined depression 
appears to be the most useful for screening purposes. A Norwegian validation study (Berle et 
al., 2003) recommended the cut-off for minor depression for screening purposes in clinical 
settings to detect women at risk for developing depression and to identify those who have 
19 
 
minor depression. Identifying women with a psychiatric disorder in pregnancy is of special 
interest, because they are less likely to attend antenatal clinic appointments as appropriate 
(Zuckerman et al., 1989), and depression, one of the commonest reasons, is relatively easy 
and cheap to screen for. A further argument for studying antenatal depression is the 
significant association of AND with PND (Robertson et al., 2004), which with the treatment 
of the AND can often be prevented. 
Antenatal validation of the EPDS in particular populations in each trimester in every 
culture is highly recommended before the instrument can be used properly for screening for 
AND. The message from the antenatal validation studies is clear: antenatal cut-off values are 
different from the postnatal ones (France: 11.5 antenatal (Adouard et al., 2005;) vs 10.5 in 
postnatal (Guedeney and Fermanian, 1998), UK: 14.5 antenatal (Murray and Cox, 1990) vs 
12.5 postnatal (Cox et al., 1987), Malta: 13.5 antenatal (Felice et al., 2004) vs 11.5 postnatal 
(Felice et al., 2006), Nigeria: 9.5 antenatal (Adewuya et al., 2006) vs 8.5 postnatal (Uwakwe 
and Okonkwo, 2003), Hungary: 6.5 antenatal (Töreki et al., 2014) vs 12.5 postnatal (Nagy et 
al., 2011; or Töreki et al., 2013); Lithuania: 6.5 antenatal (Bunevicius et al., 2009a) vs. 10.5-
11.5 postnatal (Bunevicius et al., 2009b); Taiwan: 12.5-13.5 antenatal (Su et al., 2007) vs. 
12.5 postnatal (Teng et al., 2005); Mainland China: 9.5 antenatal (Wang et al., 2009) vs. 10.5 
postnatal (Lau et al., 2010) and Sweden: 13.5 antenatal (Rubertsson et al., 2011) vs. 11.5 
postnatal (Wickberg and Hwang, 1997). In general, the cut-offs are lower in the post- than in 
the antenatal period. Taking into consideration the trimester in which the validation took place 
is also important, because the prevalence of depression may fluctuate during the course of 
pregnancy and, as a consequence, the optimal cut-off of EPDS may also be different. 
The difference in the EPDS cut-off scores among the studies may also be partly due to 
differences in the time of assessment in relation to childbirth (early or late pregnancy, early or 
late post partum) (Alvarado-Esquivel et al., 2006; Bunevicius et al., 2009a). Su et al. (Su et 
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al., 2007) stated that they avoided validating the EPDS in the first trimester of the pregnancy 
due to the possible acute psychological effects of pregnancy; however this was not 
recognizable in other studies (Bunevicius et al., 2009a; Bergink et al., 2011; Töreki et al., 
2014). 
Cultural adaptation is necessary even in countries speaking the same language. E.g. 
the New-Zealand (Boyce and Todd, 1992) and English version (Cox et al., 1987) or the 
Spanish (Garcia-Esteve et al., 2003) and Mexican versions (Alvarado-Esquivelet al., 2006) 
gave different cut-offs in postnatal samples. 
There is a trade-off between validating in clinical versus community samples (e.g. 
Berle et al., 2003 vs. Eberhard-Gran et al., 2001 or Nagy et al., 2011 vs. Töreki et al., 2013). 
The second option may provide values more representative to the general population, but it 
may only be possible to use structured clinical interviews as gold standard for diagnosis 
(which is more acceptable than self-report symptom measures that are often used in 
community studies) in smaller, clinical samples. 
Higher prevalence of depression in the sample, which can be due to selection bias, can 
lead to a falsely high PPV, which in turn may influence our decision regarding the 
recommended cut-off value (Bergink et al., 2011). 
Apart from the Hungarian and the Swedish studies (Töreki et al., 2014; Rubertsson et 
al., 2011), no other study described how many approached pregnant women declined to 
participate and whether those who declined were different from participants in terms of 
sociodemographic characteristics or EPDS scores. Also, they do not report the criteria used 
for the diagnosis of minor depression. There are discrepancies in what is meant by antenatal 
depression in terms of criteria (Leight et al., 2010). Establishing international consensus with 
regard to this would be helpful for future research. 
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In conclusion, currently, versions of the EPDS validated in an antepartum sample are 
available in Chinese, Dutch English, French, Hungarian, Lithuanian, Maltese, Nigerian, and 
Portuguese. It is suggested that the EPDS be validated in every country in each trimester 
during pregnancy. Also, test-retest reliability indices of the EPDS were not assessed in most 
of the studies discussed in the current review and the EPDS was only administered on one 
occasion. However, in the studies that did report figures, short-term (Wang et al., 2009; 
Töreki et al., 2014) and long-term retest validity was good (Bergink et al., 2011). 
 
Large confidence intervals 
 
When estimating the sensitivity, specificity and predictive values as screening 
properties of an instrument, narrow confidence intervals would be desirable (Eberhard-Gran 
et al., 2001). Our estimates reveal variable 95% confidence intervals for the sensitivity, 
specificity and predictive values in most of the validation studies, which reflect the possibility 
of the low number of participants, the prevalence of identifiable depression cases and 
differences in characteristics of the EPDS version applied. It would be advisable to achieve 
larger samples in future validation studies. 
 
Limitations 
 
This systematic review has confirmed that the screening accuracy of the EPDSin 
diagnosing depression during pregnancy is satisfactory and that the EPDS can be 
recommended for use for this purpose. The heterogeneity of included studies prevented 
progression to meta–analysis and further statistical comparison of the EPDS across settings 
was not possible. 
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